marijuana stocks news

Form 8-K for CHUMA HOLDINGS, INC.

13-Jan-2015

Other Events

Item 8.01 Other Events.Effective January 9, 2015, the British Columbia Securities Commission (the “BCSC”), the market regulatory authority in the province of British Columbia, Canada, issued a temporary halt trade order on Chuma Holdings, Inc.’s (the “Company”) common stock which halted trading in the stock in the province of British Columbia until the end of business on January 29, 2015. The Company is informed and believes that this temporary halt trade order is directly related to unauthorized third party investor relations promotional campaigns discovered by the Company and disclosed via Company press release on January 9, 2015.

The Company further believes that the offending promotional campaigns have since been taken down. The Company will continue to work closely with the BCSC to ensure that citizens of British Columbia will be able to resume trading in the Company’s common stock as soon as possible. The Company again would like to reiterate that it focuses upon ensuring that all public communications are accurate and in compliance with applicable securities laws and cautions investors about relying on unauthorized promotional campaigns.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc. (TBPMF) Adds Two Board Members and Appoints New COO

Tetra Bio-Pharma Adds Two Board Members and Appoints New COO Tetra Bio-Pharma…

Cara Therapeutics, Inc. (CARA) to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

Cara Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare…

$VHUB Launches New Sleeve Design: Multiple Colors, Logos

Vapor Hub International Launches New Sleeve Design: Multiple Colors, Logos Vapor Hub…

GT Biopharma Inc. (OXISD) Announces Reverse Stock Spilt As Part of Planned Merger

GT Biopharma, Inc. Announces Reverse Stock Spilt As Part of Oxis-Georgetown Planned…